SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-024298
Filing Date
2023-03-30
Accepted
2023-03-30 07:54:28
Documents
88
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2022_canfitebio.htm   iXBRL 20-F 2336700
2 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF CAN-FITE BIOPHARMA LTD f20f2022ex1-1_canfitebio.htm EX-1.1 253318
3 CERTIFICATION f20f2022ex12-1_canfitebio.htm EX-12.1 9382
4 CERTIFICATION f20f2022ex12-2_canfitebio.htm EX-12.2 9635
5 CERTIFICATION f20f2022ex13-1_canfitebio.htm EX-13.1 4051
6 CERTIFICATION f20f2022ex13-2_canfitebio.htm EX-13.2 4235
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f20f2022ex15-1_canfitebio.htm EX-15.1 5393
8 GRAPHIC image_001.jpg GRAPHIC 59976
9 GRAPHIC image_002.jpg GRAPHIC 43273
10 GRAPHIC image_003.jpg GRAPHIC 20751
11 GRAPHIC image_004.jpg GRAPHIC 2492
12 GRAPHIC image_005.jpg GRAPHIC 48875
13 GRAPHIC image_006.jpg GRAPHIC 84910
14 GRAPHIC image_007.jpg GRAPHIC 48202
  Complete submission text file 0001213900-23-024298.txt   8169956

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE canf-20221231.xsd EX-101.SCH 78784
16 XBRL CALCULATION FILE canf-20221231_cal.xml EX-101.CAL 28133
17 XBRL DEFINITION FILE canf-20221231_def.xml EX-101.DEF 250236
18 XBRL LABEL FILE canf-20221231_lab.xml EX-101.LAB 559204
19 XBRL PRESENTATION FILE canf-20221231_pre.xml EX-101.PRE 264817
82 EXTRACTED XBRL INSTANCE DOCUMENT f20f2022_canfitebio_htm.xml XML 638319
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36203 | Film No.: 23777187
SIC: 2834 Pharmaceutical Preparations